摘要
目的 心肌细胞的自噬受到非常精细地调节,本实验探讨ω-3不饱和脂肪酸是否能通过影响自噬改善心肌细胞损伤并深入研究其机制。方法 使用H9C2细胞系以及成年C57BL/6小鼠心肌细胞原代培养,将心肌细胞暴露于血管紧张素Ⅱ和ω-3不饱和脂肪酸环境中,检测心肌细胞结构稳定性和心肌细胞自噬状态,检测指标包括心肌细胞骨架蛋白α-Actinin变化情况变化、细胞自噬流水平变化及细胞自噬相关蛋白变化等。结果 血管紧张素Ⅱ诱导心肌细胞中α-Actinin纤维排列消失,变为散点状结构。ω-3多不饱和脂肪酸使心肌细胞α-Actinin纤维排列结构保持正常。血管紧张素Ⅱ可诱导心肌细胞自噬流明显上调(P<0.01),而ω-3多不饱和脂肪酸可抑制暴露于血管紧张素Ⅱ的H9c2细胞自噬水平(P<0.01)。血管紧张素Ⅱ提升细胞LC3Ⅱ/LC3Ⅰ表达,而ω-3多不饱和脂肪酸能够抑制LC3Ⅱ/LC3Ⅰ水平的升高。结论 ω-3多不饱和脂肪酸可通过调节自噬水平来减轻心肌细胞的结构损伤。
Objective Autophagy in cardiomyocytes is very finely regulated. The present study explored whether ω-3 unsaturated fatty acids could improve cardiomyocyte injury by affecting autophagy and its mechanism.Methods H9C2 cell line and primary culture of adult C57BL/6 mouse cardiomyocytes are used for experiments.Cardiac cells were exposed to angiotensin Ⅱ and Omega-3 unsaturated fatty acids. Autophagy and cell myofibril stabilization situation was detected. Detection indicators include changes in cardiac cytoskeletal protein α-Actinin,changes in autophagy flux levels, and changes in autophagy-related proteins. Results Angiotensin Ⅱinduction in cardiomyocytes α-The actinin fiber arrangement disappeared and became a scattered structure. ω-3 PUFAs prime cardiomyocytes α-Actinin fiber alignment structure remained normal. Autophagic flux in cardiomyocytes was significantly upregulated by angiotensin Ⅱ(P<0.01 ω-3 PUFA inhibited autophagy in H9c2 cells exposed to angiotensin Ⅱ(P<0.01). Angiotensin II elevated cellular lc3ii/lc3i expression, whereas ω-3 PUFAs can suppress the increase in lc3ii/lc3i levels. Conclusion Polyunsaturated fatty acids can reduce the structural damage of cardiomyocytes by regulating the level of autophagy.
作者
石苗茜
苏菲菲
石宇杰
田新利
崔振双
韩运峰
田建伟
李俊峡
Shi Miaoqian;Su Feifei;Shi Yujie;Tian Xinli;Cui Zhenshuang;Han Yunfeng;Tian Jianwei;Li Junxia(Department of Cardiology,Seventh Medical Center of Chinese PLA General Hospital,Beijing 100700,China;不详)
出处
《中国循证心血管医学杂志》
2022年第8期971-974,978,共5页
Chinese Journal of Evidence-Based Cardiovascular Medicine
基金
中国人民解放军第七医学中心院内创新培育课题(2019)
北京市海淀区科研培育计划项目(HP2021-03-80802)
中国人民解放军空军特色医学中心科技助推计划课题(2020KTC20)。